Vaseem Mahboob
CIK 1655157 · Chief Financial Officer · last filed 2026-06-04
Vaseem Mahboob is a Chief Financial Officer who has filed 23 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for KMTS, was dated Jun 4, 2026. Across all open-market trades the lifetime net is +$297.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.42M
3
23
$297.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KMTS | Chief Financial Officer | 67,961 | $20.85 | $1.42M | $0 | 2 | 2026-06-04 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Chief Financial Officer | 111,716 | — | — | $297.9K | 18 | 2020-03-26 |
| Insys Therapeutics, Inc. (INSY) Delisted | Director | 14,083 | — | — | $0 | 3 | 2019-04-23 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | KMTS | Grant (A) | +25,227 | $0 | EDGAR |
| 2025-07-21 | KMTS | Grant (A) | +22,059 | $0 | EDGAR |
| 2020-03-26 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | +43,385 | -$3.4K | EDGAR |
| 2020-01-02 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | +43,617 | -$5.7K | EDGAR |
| 2019-12-17 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | +44,024 | -$7.6K | EDGAR |
| 2019-10-01 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | — | $0 | EDGAR |
| 2019-08-06 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Grant (A) | +32,400 | $0 | EDGAR |
| 2019-04-23 | Insys Therapeutics, Inc. (INSY) Delisted | Grant (A) | +8,083 | $0 | EDGAR |
| 2019-04-19 | Insys Therapeutics, Inc. (INSY) Delisted | Grant (A) | +8,083 | $0 | EDGAR |
| 2019-04-03 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | +27,628 | $100.0K | EDGAR |